Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2232 (LINC02232) is a human gene that encodes a long intergenic non-coding RNA (lincRNA)[1]. LincRNAs are a subclass of long non-coding RNAs, typically defined as non-protein-coding transcripts longer than 200 nucleotides that do not overlap protein-coding genes[3]. These RNAs frequently modulate gene expression and chromatin states, sometimes exerting regulatory effects on neighboring genes through diverse mechanisms such as chromatin remodeling, transcriptional regulation, or interaction with other nucleic acids or proteins[3]. However, the biological role and regulatory mechanisms for LINC02232 specifically have not been described in published functional studies to date[1]. As such, it cannot be classified within traditional receptor, transcription factor, or enzyme target families, and no therapeutic drugs or clinically relevant interactions have been established.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2232 (LINC02232).